143 related articles for article (PubMed ID: 29081245)
1. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?
Beltran BE; Quiñones P; Sanchez G; Paredes A; Moises C; Cotrina E; Torres-Cabala CA; Miranda RN; Castillo JJ
Leuk Lymphoma; 2018 Jul; 59(7):1753-1755. PubMed ID: 29081245
[No Abstract] [Full Text] [Related]
2. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
3. A rare presentation of plasmablastic lymphoma as cutaneous nodules in an immunocompromised patient.
Mani SS; Kodiatte T; Jagannati M
Int J STD AIDS; 2017 May; 28(6):623-625. PubMed ID: 27738277
[TBL] [Abstract][Full Text] [Related]
4. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report.
Romero M; González-Fontal GR; Saavedra C; Guerra J; Quintero G; Quijano S; Ney D; Henao-Martínez AF
Diagn Cytopathol; 2016 Jan; 44(1):61-5. PubMed ID: 26468050
[No Abstract] [Full Text] [Related]
5. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome.
Fakhri B; Cashen AF; Duncavage EJ; Watkins MP; Wartman LD; Bartlett NL
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e532-e535. PubMed ID: 31279773
[No Abstract] [Full Text] [Related]
6. Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity.
Mota F; Mesquita B; Carvalho S; Coelho A; Velho G; Lima M; Selores M
Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617520
[TBL] [Abstract][Full Text] [Related]
7. Successful Use of Bortezomib-Lenalidomide Combination as Treatment for a Patient With Plasmablastic Lymphoma.
Marrero WD; Cruz-Chacón A; Castillo C; Cabanillas F
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):e275-e277. PubMed ID: 29753690
[No Abstract] [Full Text] [Related]
8. Primary cutaneous mantle cell lymphoma.
Zattra E; Zambello R; Marino F; Bordignon M; Alaibac M
Acta Derm Venereol; 2011 Jun; 91(4):474-5. PubMed ID: 21537825
[No Abstract] [Full Text] [Related]
9. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.
Marini C; Baldaia H; Trigo F; Castillo JJ
Am J Hematol; 2016 Aug; 91(8):E324. PubMed ID: 27012155
[No Abstract] [Full Text] [Related]
10. Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.
Sharma P; Sreedharanunni S; Koshy A; Prakash G; Sachdeva MUS; Malhotra P
Indian J Pathol Microbiol; 2019; 62(1):107-110. PubMed ID: 30706870
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion.
Yoshihara K; Yoshihara S; Matsuda I; Imado T; Matsuo S; Okada M; Shimizu Y; Hirota S; Fujimori Y
Ann Hematol; 2020 Jun; 99(6):1405-1407. PubMed ID: 32125468
[No Abstract] [Full Text] [Related]
12. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
Harmon CM; Smith LB
Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
[TBL] [Abstract][Full Text] [Related]
13. Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Pretscher D; Kalisch A; Wilhelm M; Birkmann J
Ann Hematol; 2017 Jun; 96(6):967-970. PubMed ID: 28011983
[TBL] [Abstract][Full Text] [Related]
14. Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma.
Carras S; Regny C; Peoc'h M; Gervasoni J; Gressin R; Cahn JY; Molina L
Leuk Lymphoma; 2015; 56(10):2986-8. PubMed ID: 25676034
[No Abstract] [Full Text] [Related]
15. An Endotracheal Plasmablastic Lymphoma.
Bots EMT; Opperman J; Bassa F; Koegelenberg CFN
Respiration; 2019; 98(6):546-550. PubMed ID: 31634891
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Bortezomib in the Management of Plasmablastic Lymphoma.
Umeanaeto O; Gamboa J; Diaz J; Hakim MN; Corral J; Philipovskiy A; Gaur S
Anticancer Res; 2019 Sep; 39(9):5003-5007. PubMed ID: 31519607
[TBL] [Abstract][Full Text] [Related]
17. [Primary cardiac plasmablastic lymphoma: report of a case and literature review].
Zhu J; Li Q; Zeng W; Wu Z; Fan L; Xu W; Li J
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):862-5. PubMed ID: 26477767
[TBL] [Abstract][Full Text] [Related]
18. Solitary plasmablastic lymphoma in the esophagus.
Mihara K; Sasaki N; Mamoru O; Kanbe M; Ichinohe T; Suehiro S
Ann Hematol; 2016 Apr; 95(5):845-6. PubMed ID: 26925582
[No Abstract] [Full Text] [Related]
19. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
20. Lacrimal gland anaplastic kinase-positive large B-cell lymphoma (LBCL-ALK+) with an atypical clinical presentation.
Duarte AF; Squire JA; Chahud F; Cruz AA
Clin Exp Ophthalmol; 2016 Aug; 44(6):520-2. PubMed ID: 26753905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
